Provider
P23-18 Clinical Reviews for Court-Ordered Substance Use Disorder Treatment
Program effective Date: Jun 01, 2018
Documents & Forms Results
Displaying 2841 - 2850 of 3159 results
Provider
P26-18 New Commercial Pre-Authorization Requirements for Partial Hospitalization
Program effective Date: Jun 01, 2018
Provider
QP40-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Selective Serotonin Inverse Agonist (SSIA)
Program effective Date: May 31, 2018
Provider
QP38-18 Learning Environment for Risk Adjustment and Value Based Topics
Program effective Date: May 25, 2018
Provider
2018 June Provider Press
Program effective Date: May 23, 2018
Provider
QP37-18 Pharmacy Benefit Update - Brand Copaxone 20mg/mL and 40 mg/ML Non-Formulary
Program effective Date: May 21, 2018
Provider
QP36-18 Pre-Admission Notification Update Effective May 21, 2018
Program effective Date: May 18, 2018
Provider
QP35-18 Pharmacy Benefit Exclusion for Ilumya (tildrakizumab-asmn)
Program effective Date: May 18, 2018
Provider
QP33-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) Criteria: Strensiq (asfotase alfa)
Program effective Date: May 15, 2018
Provider
QP34-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Uric Acid Transport 1 (URAT1) Inhibitor
Program effective Date: May 15, 2018